1.Chronic Starvation Stress Promotes Migration Ability of Colorectal Cancer Cells by Inducing ITGB1 Upregulation
Siyu LI ; Jinghua CAO ; Fengwei WANG
Cancer Research on Prevention and Treatment 2024;51(4):240-248
Objective To investigate the effects of chronic starvation stress on the proliferation and migration of colorectal cancer cells, as well as the underlying mechanisms. Methods By using prolonged serum starvation to simulate chronic starvation stress in tumor cells, we established enduring serum-deprived models of SW480 and DLD-1 cells and observed cellular morphological change. Effects of prolonged serum starvation on SW480 and DLD-1 proliferative and migratory capabilities were assessed using CCK-8 and Transwell assays. Differential gene-expression analysis on SW480 cultured with 1% FBS or 10% FBS medium was followed by GO and KEGG pathway assessments. Migration-related protein interactions were explored using String database and Metascape software, leading to 16 genes being selected for RT-qPCR validation. Protein levels of ITGB1 and key molecules in the relevant pathways were measured. Mobility changes in SW480 were observed through Transwell assay after ITGB1 knockdown or STAT3 inhibition. Results Prolonged serum starvation significantly inhibited the proliferation of SW480 and DLD-1 cells, and DLD-1 mobility, while enhanced SW480 migration. Transcriptome analysis revealed that prolonged serum deprivation caused the upregulation of 3016 genes, among which 283 were involved in cell migration. Metascape analysis identified the correlations among potential core genes
2.Seroprevalence of influenza viruses in Shandong, Northern China during the COVID-19 pandemic.
Chuansong QUAN ; Zhenjie ZHANG ; Guoyong DING ; Fengwei SUN ; Hengxia ZHAO ; Qinghua LIU ; Chuanmin MA ; Jing WANG ; Liang WANG ; Wenbo ZHAO ; Jinjie HE ; Yu WANG ; Qian HE ; Michael J CARR ; Dayan WANG ; Qiang XIAO ; Weifeng SHI
Frontiers of Medicine 2022;():1-7
Nonpharmaceutical interventions (NPIs) have been commonly deployed to prevent and control the spread of the coronavirus disease 2019 (COVID-19), resulting in a worldwide decline in influenza prevalence. However, the influenza risk in China warrants cautious assessment. We conducted a cross-sectional, seroepidemiological study in Shandong Province, Northern China in mid-2021. Hemagglutination inhibition was performed to test antibodies against four influenza vaccine strains. A combination of descriptive and meta-analyses was adopted to compare the seroprevalence of influenza antibodies before and during the COVID-19 pandemic. The overall seroprevalence values against A/H1N1pdm09, A/H3N2, B/Victoria, and B/Yamagata were 17.8% (95% CI 16.2%-19.5%), 23.5% (95% CI 21.7%-25.4%), 7.6% (95% CI 6.6%-8.7%), and 15.0 (95% CI 13.5%-16.5%), respectively, in the study period. The overall vaccination rate was extremely low (2.6%). Our results revealed that antibody titers in vaccinated participants were significantly higher than those in unvaccinated individuals (P < 0.001). Notably, the meta-analysis showed that antibodies against A/H1N1pdm09 and A/H3N2 were significantly low in adults after the COVID-19 pandemic (P < 0.01). Increasing vaccination rates and maintaining NPIs are recommended to prevent an elevated influenza risk in China.
3.Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer.
Jun NI ; Miao HUANG ; Li ZHANG ; Nan WU ; Chunxue BAI ; Liang'an CHEN ; Jun LIANG ; Qian LIU ; Jie WANG ; Yilong WU ; Fengchun ZHANG ; Shuyang ZHANG ; Chun CHEN ; Jun CHEN ; Wentao FANG ; Shugeng GAO ; Jian HU ; Tao JIANG ; Shanqing LI ; Hecheng LI ; Yongde LIAO ; Yang LIU ; Deruo LIU ; Hongxu LIU ; Jianyang LIU ; Lunxu LIU ; Mengzhao WANG ; Changli WANG ; Fan YANG ; Yue YANG ; Lanjun ZHANG ; Xiuyi ZHI ; Wenzhao ZHONG ; Yuzhou GUAN ; Xiaoxiao GUO ; Chunxia HE ; Shaolei LI ; Yue LI ; Naixin LIANG ; Fangliang LU ; Chao LV ; Wei LV ; Xiaoyan SI ; Fengwei TAN ; Hanping WANG ; Jiangshan WANG ; Shi YAN ; Huaxia YANG ; Huijuan ZHU ; Junling ZHUANG ; Minglei ZHUO
Chinese Journal of Lung Cancer 2021;24(3):141-160
BACKGROUND:
Perioperative treatment has become an increasingly important aspect of the management of patients with non-small cell lung cancer (NSCLC). Small-scale clinical studies performed in recent years have shown improvements in the major pathological remission rate after neoadjuvant therapy, suggesting that it will soon become an important part of NSCLC treatment. Nevertheless, neoadjuvant immunotherapy may be accompanied by serious adverse reactions that lead to delay or cancelation of surgery, additional illness, and even death, and have therefore attracted much attention. The purpose of the clinical recommendations is to form a diagnosis and treatment plan suitable for the current domestic medical situation for the immune-related adverse event (irAE).
METHODS:
This recommendation is composed of experts in thoracic surgery, oncologists, thoracic medicine and irAE related departments (gastroenterology, respirology, cardiology, infectious medicine, hematology, endocrinology, rheumatology, neurology, dermatology, emergency section) to jointly complete the formulation. Experts make full reference to the irAE guidelines, large-scale clinical research data published by thoracic surgery, and the clinical experience of domestic doctors and publicly published cases, and repeated discussions in multiple disciplines to form this recommendation for perioperative irAE.
RESULTS:
This clinical recommendation covers the whole process of prevention, evaluation, examination, treatment and monitoring related to irAE, so as to guide the clinical work comprehensively and effectively.
CONCLUSIONS
Perioperative irAE management is an important part of immune perioperative treatment of lung cancer. With the continuous development of immune perioperative treatment, more research is needed in the future to optimize the diagnosis and treatment of perioperative irAE.
4.KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma.
Shi WEI ; Miaomiao DAI ; Chi ZHANG ; Kai TENG ; Fengwei WANG ; Hongbo LI ; Weipeng SUN ; Zihao FENG ; Tiebang KANG ; Xinyuan GUAN ; Ruihua XU ; Muyan CAI ; Dan XIE
Protein & Cell 2021;12(10):788-809
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is the fourth-leading cause of cancer-related deaths worldwide. HCC is refractory to many standard cancer treatments and the prognosis is often poor, highlighting a pressing need to identify biomarkers of aggressiveness and potential targets for future treatments. Kinesin family member 2C (KIF2C) is reported to be highly expressed in several human tumors. Nevertheless, the molecular mechanisms underlying the role of KIF2C in tumor development and progression have not been investigated. In this study, we found that KIF2C expression was significantly upregulated in HCC, and that KIF2C up-regulation was associated with a poor prognosis. Utilizing both gain and loss of function assays, we showed that KIF2C promoted HCC cell proliferation, migration, invasion, and metastasis both in vitro and in vivo. Mechanistically, we identified TBC1D7 as a binding partner of KIF2C, and this interaction disrupts the formation of the TSC complex, resulting in the enhancement of mammalian target of rapamycin complex1 (mTORC1) signal transduction. Additionally, we found that KIF2C is a direct target of the Wnt/β-catenin pathway, and acts as a key factor in mediating the crosstalk between Wnt/β-catenin and mTORC1 signaling. Thus, the results of our study establish a link between Wnt/β-catenin and mTORC1 signaling, which highlights the potential of KIF2C as a therapeutic target for the treatment of HCC.
Adult
;
Aged
;
Animals
;
Carcinoma, Hepatocellular/pathology*
;
Cell Line, Tumor
;
Cell Movement
;
Cell Proliferation
;
Epithelial-Mesenchymal Transition/genetics*
;
Female
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Intracellular Signaling Peptides and Proteins/metabolism*
;
Kinesins/metabolism*
;
Liver Neoplasms/pathology*
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Middle Aged
;
Neoplasm Staging
;
Prognosis
;
Protein Binding
;
RNA, Small Interfering/metabolism*
;
Survival Analysis
;
Tumor Burden
;
Wnt Signaling Pathway
;
Xenograft Model Antitumor Assays
;
beta Catenin/metabolism*
5.Dosage effects in treating tiptoe deformity in children with spastic cerebral palsy using botulinum toxin type A
Dengna ZHU ; Ruimin LIU ; Jun WANG ; Junying YUAN ; Fengwei LIU ; Guohui NIU ; Yongqiang GAO ; Wei ZHANG ; Sansong LI ; Yiwen WANG ; Erliang SUN ; Guangyu ZHANG ; Lei YANG ; Yunxia ZHAO ; Mingmei WANG
Chinese Journal of Physical Medicine and Rehabilitation 2020;42(5):424-428
Objective:To observe the clinical efficacy and side effects of injecting different doses of botulinum toxin type A (BTX-A) into children with spastic cerebral palsy (CP) and tiptoe deformity.Methods:A total of 107 children with tiptoe deformity resulting from CP were divided into group A ( n=35), group B ( n=36) and group C ( n=36) using a random number table. Group A received 3u/kg injections of BTX-A, group B received 4u/kg injections and group C received 5u/kg. The injections were guided by color Doppler ultrasound and followed by 4 courses of rehabilitation therapy. Before and 1, 3 and 6 months after the treatment, the modified Tardieu scale (MTS) was used to assess gastrocnemius spasms, while sections D and E of gross motor function scale 88 (GMFM-88) and the pediatric balance scale (PBS) were used to evaluate motor functioning and balance. Any side effects were also observed. Results:After the treatment, improvement was observed in all of the measurements, though there were no significant differences in the degree of improvement nor in the incidence of side effects among the three groups.Conclusions:There is no significant difference in clinical efficacy or side effects involved in using different doses of BTX-A to treat tiptoe deformity in children with spastic cerebral palsy. The recommended dosage is therefore 3u/kg.
6.Quality assessment of guidelines and consensus in lung cancer chemotherapy
Yaping ZHOU ; Min YANG ; Pengtao YAO ; Yibing GE ; Wei TANG ; Yan WEN ; Zhangyan LYU ; Fengwei TAN ; Xin SUN ; Fang LI ; Jiang LI ; Ni LI
Chinese Journal of Oncology 2020;42(12):1025-1033
Objective:To understand the current status of clinical guidelines and consensus for lung cancer chemotherapy, evaluate and analyze the quality of lung cancer chemotherapy treatment guidelines, and provide references for the revision and improvement of lung cancer chemotherapy clinical decision-making and guidelines.Methods:Search Pubmed, EMbase, Cochrane Library (Cochrane Library), China Knowledge Network, Wanfang Database, China Biomedical Literature Database and other related databases and clinical practice guidelines related to lung cancer chemotherapy, and screen the literatures according to the established inclusion exclusion criteria. Use the appraisal of guidelines for research and evaluation Ⅱ (AGREE Ⅱ) and reporting items for practice guidelines in healthcare (RIGHT) tools to compare and evaluate the quality of the included guides and the level of reporting specifications.Results:A total of 14 guidelines were included. The assessment results of AGREE Ⅱ showed that the average score of scope and purpose was 94 points, the average score of stakeholder involvement was 60 points, the average score of rigour of development was 43 points, the average score of clarity of presentation was 88 points, the average score of applicability was 50 points, the average score of editorial independence was 61 points. Seven guidelines were evaluated as A level, 6 guidelines were evaluated as B level, 1 guideline was evaluated as C level. The assessment results of RIGHT showed that, in addition to the basic information, the included guidelines have many deficiencies in 6 areas including background, evidence, recommendation, review and quality assurance, funding, declaration and management of interests and other information, and the normative gap between domestic and foreign guides was large.Conclusions:The overall quality of clinical guidelines for lung cancer chemotherapy is high, but the standardization needs to be strengthened. There is a big gap between the quality and standardization of domestic and foreign guides. Further developments of high-quality clinical practice guidelines and guidelines consistent with our country′s actual situation are needed.
7.Quality assessment of guidelines and consensus in lung cancer chemotherapy
Yaping ZHOU ; Min YANG ; Pengtao YAO ; Yibing GE ; Wei TANG ; Yan WEN ; Zhangyan LYU ; Fengwei TAN ; Xin SUN ; Fang LI ; Jiang LI ; Ni LI
Chinese Journal of Oncology 2020;42(12):1025-1033
Objective:To understand the current status of clinical guidelines and consensus for lung cancer chemotherapy, evaluate and analyze the quality of lung cancer chemotherapy treatment guidelines, and provide references for the revision and improvement of lung cancer chemotherapy clinical decision-making and guidelines.Methods:Search Pubmed, EMbase, Cochrane Library (Cochrane Library), China Knowledge Network, Wanfang Database, China Biomedical Literature Database and other related databases and clinical practice guidelines related to lung cancer chemotherapy, and screen the literatures according to the established inclusion exclusion criteria. Use the appraisal of guidelines for research and evaluation Ⅱ (AGREE Ⅱ) and reporting items for practice guidelines in healthcare (RIGHT) tools to compare and evaluate the quality of the included guides and the level of reporting specifications.Results:A total of 14 guidelines were included. The assessment results of AGREE Ⅱ showed that the average score of scope and purpose was 94 points, the average score of stakeholder involvement was 60 points, the average score of rigour of development was 43 points, the average score of clarity of presentation was 88 points, the average score of applicability was 50 points, the average score of editorial independence was 61 points. Seven guidelines were evaluated as A level, 6 guidelines were evaluated as B level, 1 guideline was evaluated as C level. The assessment results of RIGHT showed that, in addition to the basic information, the included guidelines have many deficiencies in 6 areas including background, evidence, recommendation, review and quality assurance, funding, declaration and management of interests and other information, and the normative gap between domestic and foreign guides was large.Conclusions:The overall quality of clinical guidelines for lung cancer chemotherapy is high, but the standardization needs to be strengthened. There is a big gap between the quality and standardization of domestic and foreign guides. Further developments of high-quality clinical practice guidelines and guidelines consistent with our country′s actual situation are needed.
8. Effect of radiotherapy for primary orbital lymphoma: analyses of 28 cases
Liuhua LONG ; Peipei SUN ; Dongrun TANG ; Xinmin DING ; Huaqing WANG ; Wenhua ZHANG ; Long ZHANG ; Tai ZHANG ; Fengwei WANG
Journal of Leukemia & Lymphoma 2018;27(4):243-245
Objective:
To analyze the effect and adverse reactions of radiotherapy in patients with primary orbital lymphoma.
Methods:
A total of 28 patients with primary orbital lymphoma from Tianjin Union Medical Center, the First Central Hospital of Tianjin and Tianjin Dagang Oil Company Hospital between March 2006 and August 2012 were retrospectively analyzed. All the patients received orbital tumor dissection or biopsy, then received radiation therapy. Three patients received chemotherapy with CHOP protocol before radiotherapy. Radiotherapy was delivered routinely with 3D-conformal radiation therapy (CRT) technique with daily 2-2.5 Gy for 5 times per week and 3-5 fields. Total dosage was 20-50 Gy. There were 18 cases of 30 Gy, 1 case of 22 Gy, 1 case of 25 Gy, 1 case of 20 Gy, 1 case of 28.8 Gy, 3 cases of 40 Gy, 1 case of 42 Gy, 1 case of 46 Gy and 1 case of 50 Gy.
Results:
All the patients had complete remission (CR) after radiotherapy during follow-up. One patient recurred after radiotherapy of 4 months and received CR with radiotherapy again. One patient died of lung infiltration. Acute complications during radiotherapy were conjunctivitis (28 cases, 100.0%) and keratitis (1 case, 3.6%), long-term complications with ophthalmoxerosis (10 cases, 35.7%) and decreased visual acuity (1 case, 3.6%).
Conclusion
Radiotherapy is an effective method for primary orbital lymphoma, and the adverse reactions can be tolerated for most patients.
9.Effect of snapshot freeze motion correction algorithm on image quality of coronary CT angiography without heart rate control
Lijuan FAN ; Fengwei SUN ; Jiwang ZHANG ; Dongsheng XU ; Donghai FU ; Liren ZHANG
Chinese Journal of Radiology 2014;48(2):105-108
Objective To assess the effect of snapshot freeze (SSF) motion correction algorithm on the image quality of coronary CT angiography (CCTA).Methods Thirty-one consecutive patients underwent coronary CTA without heart rate control.All of the CCTA images were reconstructed by the means of both standard (STD) and SSF motion correction.Image quality and interpretability of STD and SSF reconstructions were compared.CCTA images were interpreted with Likert 4-points score system by two experienced radiologists.The image qualities were assessed on per-artery and per-segment level,and interpretability was performed on per-segment,per-artery,and per-patient levels.Comparisons of variables were performed with paired Wilcoxon rank sum test and paired Chi-square test.Results SSF reconstructions showed higher interpretability than STD reconstructions on per-patient [100.0% (31/31) vs 64.5% (20/31),x2 =9.09,P =0.002] and per-artery [100.0% (124/124) v s 83.9% (104/124),x2 =18.05,P =0.001] and per-segment level [99.0% (413/417) vs 89.2% (372/417),x2 =35.56,P =0.001].Image qualities were higher with the use of SSF than STD reconstructions on LAD [3.3 ± 0.7 vs 2.9 ± 1.0,Z =2.70,P=0.007],LCX [3.1 ±0.8 vs 2.5 ± 1.1,Z =3.23,P =0.001] and RCA [3.3 ±0.6 vs 2.1 ±0.9,Z =4.60,P =0.001],but they were similar on LM [3.9 ± 0.4 vs 3.7 ± 0.6,Z =1.89,P =0.059].Image quality was higher with the use of SSF versus STD reconstructions on per-segment [3.5 ± 0.7 vs 3.0 ± 1.0,Z =10.31,P =0.001] level.Conclusions The use of SSF motion correction algorithm improves image quality and interpretability of coronary CTA without heart rate control.
10.The value of volume helical shuttle of high-definition CT in clinical path of tetralogy of Fallot in children
Dongsheng XU ; Fengwei SUN ; Lijuan FAN ; Liren ZHANG ; Xu LI ; Pipi YANG
Chinese Journal of Thoracic and Cardiovascular Surgery 2013;29(11):644-648
Objective To discuss the value of volume helical shuttle(VHS) of high-definition CT(HDCT) in diagnosis and clinical path of tetralogy of Fallot(TOF).Methods 88 preschool children with TOF were examined with VHS of HDCT and echocardiography(ECHO).60 children were received surgery.Based on surgical data,the results of VHS of HDCT were compared with that of ECHO,assessing the display ability of basic deformity of TOF,the intra-cardiac lesion,extra-cardiac lesion and hemodynamics.The radiation dose(mSy) were calculated.Results The diagnostic accuracy of HDCT was 95.0% and the ECHO was 90.0% on the positional display.The results of HDCT were slightly smaller than ECHO on the measure of size of VSD,P < 0.05,the difference was significant between the two methods.The display on right-to-left shunt of VSD using HDCT were all coincided with ECHO.One quarter of the cases showed the left-to-right shunt simultaneously.Whereas all the cases were showed slow bi-directional shunt by ECHO.There are 99 deformity in pulmonary artery stenosis,including right ventricular hypertrophy,outflow tract stenosis,pulmonary stenosis.The results of HDCT,ECHO and the operation showed no difference.All the McGoon ratio of HDCT were obviously higher than ECHO,P <0.01.Statistical difference was significant.The coincidence rates in aortic straddles by HDCT and ECHO both were 98.3%.Each has one case misdiagnosed.37 other intra-cardiac lesions,for example,foramen ovale and atrial septal defect.VAS has 25 misdiagnosed places and ECHO has 8.88 other extra-cardiac lesions,such as one side of pulmonary artery stenosis or atresia,collateral circulation between systemic and pulmonary circulation,coronary artery abnormal,patent ductus arteriosus(PDA) and so on.The diagnostic accuracy of HDCT was 98.8% and the ECHO was 59.1%.Average effective dose with HDCT was(1.58 ± 0.43) mSv.Conclusion VHS of HDCT scan has obvious advantages in the diagnosis of TOF.Multiple data can reflect intra-cardiac lesion,extra-cardiac lesion accurately and intuitively.The radiation dose was in the acceptable range.Combining the HDCT VHS and the ECHO will become the clinical path of preoperative diagnosis,differential diagnosis and making the operation scheme in children with TOF.

Result Analysis
Print
Save
E-mail